Adverse event totals15

The totals the trial posted for each group.

1 to 15 of 15

Total	Group	Affected	At risk
Total, all-cause mortality	Placebo
Total, all-cause mortality	BA058 20 µg
Total, all-cause mortality	BA058 40 µg
Total, all-cause mortality	BA058 80 µg
Total, all-cause mortality	Teriparatide
Total, other adverse events	Placebo	30	45
Total, other adverse events	BA058 20 µg	31	43
Total, other adverse events	BA058 40 µg	32	43
Total, other adverse events	BA058 80 µg	33	45
Total, other adverse events	Teriparatide	35	45
Total, serious adverse events	Placebo	1	45
Total, serious adverse events	BA058 20 µg	2	43
Total, serious adverse events	BA058 40 µg	0	43
Total, serious adverse events	BA058 80 µg	2	45
Total, serious adverse events	Teriparatide	0	45

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00542425/event-totals